Low Dose Aspirin for the Prevention of Postpartum Related Breast Cancer

Summary

This phase II trial tests whether low-dose aspirin can affect markers of inflammation in postpartum (after childbirth) women planning to have a breast biopsy. Chronic inflammation may increase the risk of postpartum related breast cancer. Low-dose aspirin is a non-steroidal anti-inflammatory drug. Giving low-dose aspirin may affect markers of inflammation in blood and tissue and may prevent postpartum related breast cancer.

Timeline

Start

2023-03-09

Primary completion

2027-01-30

Completion

2027-01-30

Drugs

Indications